A Comprehensive Guide to Toxicology in Preclinical Drug Development 2013
DOI: 10.1016/b978-0-12-387815-1.00005-8
|View full text |Cite
|
Sign up to set email alerts
|

Acute, Sub-Acute, Sub-Chronic and Chronic General Toxicity Testing for Preclinical Drug Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 10 publications
0
6
0
Order By: Relevance
“…Toxicological and safety evaluation of herbal preparations are commonly performed in mouse and/or rat models [26][27][28]. The first recommended step to determine the systemic safety and toxicity of unknown compounds often involves identifying the lowest observed adverse effect level (LOEAL) and LC50 using a "single-dose" acute toxicity test [29][30][31]. Subsequently, further subacute and chronic repeated dose toxicity studies may then be performed to provide an accurate picture of the typical use of C. cainito for the treatment of subchronic (inflammation and viral infections) and chronic diseases (diabetes) [10].…”
Section: Discussionmentioning
confidence: 99%
“…Toxicological and safety evaluation of herbal preparations are commonly performed in mouse and/or rat models [26][27][28]. The first recommended step to determine the systemic safety and toxicity of unknown compounds often involves identifying the lowest observed adverse effect level (LOEAL) and LC50 using a "single-dose" acute toxicity test [29][30][31]. Subsequently, further subacute and chronic repeated dose toxicity studies may then be performed to provide an accurate picture of the typical use of C. cainito for the treatment of subchronic (inflammation and viral infections) and chronic diseases (diabetes) [10].…”
Section: Discussionmentioning
confidence: 99%
“…Toxicity may further be defined to cover the study of the adverse effects of chemicals on living organisms as well as their symptoms, mechanisms and treatments. Toxicity studies may be classified as acute, subacute/subchronic and chronic effects depending upon the quantity and duration of administration of the agents [14].…”
Section: Toxicity Of Chemicalsmentioning
confidence: 99%
“…8 Conventionally, drug administrated through skin, directly bypasses through first pass mechanism, through the stratum corneum, which is the thickest outermost layer of skin 3,9,10 To increase the skin permeability and have the drug retention, diverse approaches have been adopted, such as the use of chemical enhancer, employing iontophoresis, electroporation, and pressure wave generation (using photoacoustic or ultrasound). [18][19][20][21] Hence, there is a need of polymeric MNs, which should be biodegradable, biocompatible, and nontoxic in nature for transdermal drug delivery. Most probable alternative for transdermal drug delivery is the use of biodegradable microneedle (MNs) technology, which offer invasive route of drug administration in sustained and controlled manner delivering the drug to the specific site with less pain and tissue damage.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, toxicological assessment becomes imperative for the purpose of attaining potent and harmless formulations for clinically efficient remedies. [18][19][20][21] Hence, there is a need of polymeric MNs, which should be biodegradable, biocompatible, and nontoxic in nature for transdermal drug delivery.…”
Section: Introductionmentioning
confidence: 99%